Adnan M Hajjiah

Publications

• Case Reports   
  Tyrosine Kinase Inhibitors and Risk of Myocardial Infarction: Is there a Link?
  Author(s): Adnan M Hajjiah*, Osama Maadarani and Zuhair Bitar
  

  Abstract

  Interstitial lung disease is one of the most chronic inflammatory conditions that progressively can affect pulmonary function and patient quality of life. Tyrosine kinase inhibitors are novel medicinal agents that play a role reducing disease progression. We report a case of an acute myocardial infarction that may have been associated with the use of nintedanib; a tyrosine kinase inhibitor... Read More»
  

  • Abstract
  • Full-Text
  • PDF